Sheila Shaigany, MD, FAAD
SESSIONS
U037 Inpatient Dermatology from Horses to Zebras: Lessons Learned at an Academic Hospital
Mar 9, 2024
•
7:30 AM - 12:00 AM
•
Room 30D
F043 Treating Tumors and Inflammatory Skin Diseases with Immunomodulators and Biologics
Mar 9, 2024
•
9:00 AM - 12:00 AM
•
Room 28D
HANDOUTS
Login to view handouts
DISCLOSURES
Blueprint Medicines – Advisory Board(Honoraria); Boehringer Ingelheim – Advisory Board(Honoraria), Investigator(No Compensation Received); Hoth Therapeutics – Investigator(No Compensation Received); Priovant Therapeutics – Consultant (1099 relationship)(Honoraria), Investigator(No Compensation Received);